Chart-Typ:
Zeitraum:
| EQS-News: Immunic AG: Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments | Issuer: Immunic AG
/ Key word(s): Financing
Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
10.04.2025 / 19:00 CET/CEST
The... ► Artikel lesen |
| EQS-News: Immunic AG: Immunic, Inc. Announces Pricing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments | Issuer: Immunic AG
/ Key word(s): Financing
Immunic, Inc. Announces Pricing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
09.04.2025 / 14:10 CET/CEST
The... ► Artikel lesen |
| EQS-News: Immunic AG: Immunic, Inc. to Participate in Scientific and Industry Conferences in April | Issuer: Immunic AG
/ Key word(s): Conference
Immunic, Inc. to Participate in Scientific and Industry Conferences in April
01.04.2025 / 12:30 CET/CEST
The issuer is solely... ► Artikel lesen |
| Applied DNA Sciences, Inc.: Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA | - Pivot to U.S.-based Supply Chain for Critical Input Materials Completed - STONY BROOK, NY / ACCESS Newswire / April 21, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company")... ► Artikel lesen |
| Applied DNA Sciences, Inc.: Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement | STONY BROOK, NY / ACCESS Newswire / April 8, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that on April 7, 2025, it received... ► Artikel lesen |
| Applied DNA Sciences, Inc.: Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement | - Company Revamps Pharmacogenomics Go-To-Market Strategy, Targets Validated PGx Assay Towards Specific Use Cases - STONY BROOK, NY / ACCESS Newswire / April 1, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN)... ► Artikel lesen |
| XTI Aerospace, Inc.: XTI Aerospace Provides Full-Year 2024 Business Update and Outlines 2025 Strategic Momentum | Significant progress in aircraft design and expansion of IP portfolio sets stage for 2025 pre-orders and FAA certification advancement
ENGLEWOOD, Colo., April... ► Artikel lesen |
| XTI Aerospace, Inc.: XTI Aerospace Announces Pricing of Public Offering | ENGLEWOOD, Colo., March 28, 2025 /PRNewswire/ -- XTI Aerospace, Inc. (Nasdaq: XTIA), ("XTI" or the "Company"), a pioneer in advanced aircraft design, today announced... ► Artikel lesen |
| Pre-market Movers: Portage Biotech, XTI Aerospace, Marblegate Acquisition Corp., Cricut, Ecarx Holdings | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.25 A.M. ET).In the Green Portage Biotech Inc (PRTG) is up over 155% at $12.09.
Bowen... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NUTEX HEALTH INC finden Sie auf Wallstreet Online.
